MOVIPREP

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, United Kingdom, South Africa

Active ingredients

The drug MOVIPREP contains a combination of these active pharmaceutical ingredients (APIs):

1 Macrogol 3350
UNII G2M7P15E5P - POLYETHYLENE GLYCOL 3350

High molecular weight (4000) macrogols are long linear polymers which retain water molecules by means of hydrogen bonds. When administered by the oral route, they lead to an increase in volume of intestinal fluids.

Read about Macrogol
2 Sodium sulfate
UNII 36KCS0R750 - SODIUM SULFATE ANHYDROUS

Sodium Sulfate Anhydrous is the anhydrous, sodium salt form of sulfuric acid. Sodium sulfate anhydrous disassociates in water to provide sodium ions and sulfate ions. Sodium ion is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Sodium sulfate anhydrous is an electrolyte replenisher and is used in isosmotic solutions so that administration does not disturb normal electrolyte balance and does not lead to absorption or excretion of water and ions.

Read about Sodium sulfate
3 Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

Read about Sodium chloride
4 Potassium chloride
UNII 660YQ98I10 - POTASSIUM CHLORIDE

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.

Read about Potassium chloride
5 Ascorbic acid
UNII PQ6CK8PD0R - ASCORBIC ACID

Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs.

Read about Vitamin C
6 Sodium ascorbate
UNII S033EH8359 - SODIUM ASCORBATE

Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs.

Read about Vitamin C

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MOVIPREP Oral solution FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A06AD65 Macrogol, combinations A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AD Osmotically acting laxatives
Discover more medicines within A06AD65

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02359499
Country: EE Ravimiamet Identifier(s): 1479416, 1479427, 1479438, 1479449, 1479450, 1479461
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 340093781647, 68125, 73642
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 075187
Country: FR Base de données publique des médicaments Identifier(s): 61095956
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 113805, 113808, 113811, 182439, 182442
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6679
Country: JP 医薬品医療機器総合機構 Identifier(s): 7990102A1024
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1054742, 1054743, 1058559, 1058560, 1058561, 1058562, 1058563
Country: MT Medicines Authority Identifier(s): MA930/00101
Country: NL Z-Index G-Standaard, PRK Identifier(s): 83291
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 12733, 18009
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100248228, 100404272, 100449211, 100456020
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66152001, W66152002, W66152003, W66152004, W66152005, W66152006
Country: ZA Health Products Regulatory Authority Identifier(s): 42/11.5/0407

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.